Showing results (101-110 of 179) with videos related to
Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2004
Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populationsS Wong, J McLaughlin, D Cheng, et al.Blood|April 15, 1992
Propagation of human blastic myeloid leukemias in the SCID mouseC L Sawyers, M L Gishizky, S Quan, et al.Oncogene|June 1, 1989
P150c-abl is detected in mouse male germ cells by an in vitro kinase assay and is associated with stage-specific phosphoproteins in haploid cellsC Ponzetto, A G Wadewitz, A M Pendergast, et al.Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodiesS Nisitani, R M Kato, D J Rawlings, et al.Proceedings of the National Academy of Sciences of the United States of America|October 10, 1995
Signaling by ABL oncogenes through cyclin D1D E Afar, J McLaughlin, C J Sherr, et al.Cell|December 1, 1981
Lethal effect of the Abelson murine leukemia virus transforming gene productS F Ziegler, C A Whitlock, S P Goff, et al.Cell|July 12, 1991
BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent mannerA M Pendergast, A J Muller, M H Havlik, et al.The Journal of Experimental Medicine|April 1, 1993
Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cellsE A Faust, D C Saffran, D Toksoz, et al.Blood|May 15, 1995
Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic miceH Honda, T Fujii, M Takatoku, et al.Leukemia|December 1, 1989
P185BCR-ABL in two patients with late appearing Philadelphia chromosome-positive acute nonlymphocytic leukemiaV Najfeld, J Cuttner, A Figur, et al.Pageof 18